They will report positive data for the lumbosacral trial & the stock will trade around $4 depending on how strong the data is. The stock will trend down to the $3.50 range & they will announce a financing & reverse split of 1 for 4. They report positive data at the beginning of 2014 for PHN & then buy-out & partnership speculation continues to move it higher. We'll all be rich by the end of year.
lol 4 that's quite high. i think zlcs will go above 1 for sure before the RS, and continue to increase followed by a slight pull back while some shareholders take profits. by the end of 2014 we could see massive profits, zlcs would be a billion dollar company if the fda fast tracks the trials and completion is a certainty. by then we should see a partnership and more investors. no need for an RS. with an RS i think it will be more difficult to see huge gains. 4-5 to 20 isnt as nice as .70 to 20.